BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Prasco Laboratories Announces New, Expanded Roles for Key Executives


12/6/2011 7:31:54 AM

CINCINNATI, Dec. 6, 2011 /PRNewswire/ -- Prasco Chairman, Mr. E. Thomas Arington, announced today that Mr. Christopher H. Arington has been promoted to vice chairman and chief executive officer of Prasco. He also announced the promotion of Mr. David Vucurevich, R.Ph. to president, chief operating officer, Mr. David Furniss as chief financial officer, and Mr. Chris Gilmore vice president, strategic business ventures.

"I am extremely pleased to announce these management changes," said E. Thomas Arington. "As one of the founders of Prasco, Chris has played a critical role in the development and evolution of the company from day-to-day operations to the larger strategic picture," Arington said. "Mr. Vucurevich brings extensive experience in the pharmaceutical industry, as well as a 'get it done' management style and a commitment to excellence, which is so appropriate for Prasco at this point in time. As CFO, Mr. David Furniss brings financial acumen and over twenty years of pharmaceutical industry experience. Mr. Furniss, along with Mr. Chris Gilmore, a former Prasco Authorized Generics Business executive, will play key roles in developing and implementing new business opportunities, including acquisitions," Arington concluded.

"It is an honor to accept the position as Prasco CEO and to join Mr. David Vucurevich, in leading Prasco forward," said Chris Arington, CEO. "I am extremely pleased with Prasco's existing leadership team and we look forward to expanding Prasco's role in the pharmaceutical industry."

About Prasco Laboratories - Prasco, the Authorized Generics company, is the privately held healthcare company located in Mason, Ohio, that specializes in Authorized Generics. Prasco Authorized Generics provide patients with the identical brand drug experience at a price that competes with generics. Prasco Authorized Generics also simplify interactions between pharmacists and consumers because they are identical to branded drugs. Moreover, Prasco Authorized Generics offer brand pharmaceutical companies a strategic lifecycle management solution. For more information, visit www.prasco.com.

SOURCE Prasco Laboratories



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES